Understanding barriers to increasing physical activity in chronic pain

Understanding barriers to increasing physical activity in chronic pain: an exploratory study to develop the SUstainable Self Effective Exercise Development (SUSSED) intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN95480359

Enrollment

Registered

2020-10-05

Start date

2020-10-09

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increasing physical activity and exercise in chronic pain patients Musculoskeletal Diseases

Interventions

Up to 45 people referred to the Tayside pain service will be invited to take part in the study, aiming for a total of 40 completing the first study visit. They will take part in a semi-structured inte

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 02/11/2021: Patients: 1. Referred to Tayside pain service 2. In pain for at least 6 months 3. Pain severity: moderate to severe as assessed by pain clinic questionnaires (NRS>3) 4. No clinical contraindications to wearing Fitbit 5. Consented to being contacted for research 6. Over 18 Stakeholders: 1. Member of stakeholder population, including healthcare professionals (e.g. General practitioners (GPs)/ Allied Health Professionals (AHP)s, Nurses, pharmacists); carers, 3rd sector organisations, leisure centre staff, and others identified through the Green Health Partnership 2. Over 18 Previous participant inclusion criteria: 1. Referred to Tayside pain service 2. In pain for at least 6 months 3. Pain severity: moderate to severe as assessed by pain clinic questionnaires (NRS>3) 4. No clinical contraindications to wearing Fitbit 5. Consented to being contacted for research 6. Over 18

Exclusion criteria

Exclusion criteria: 1. Receiving active treatment for cancer 2. Unable to provide informed consent

Design outcomes

Primary

Measure	Time frame
1. Framework analyses of semi-structured interviews with patients with moderate-severe chronic pain 2. Questionnaires at baseline and 1 week: 2.1. Fear of movement measured using the Tampa Scale for Kinesiphobia 2.2. Anxiety and stress measured using the Anxiety and Stress Scale 21 2.3. Pain measured using the Brief pain inventory 2.4. Pain catastrophising measured using the Pain Catastrophising Scale 2.5. Self-efficacy measured using the Pain Self-efficacy Questionnaire 2.6. Physical activity measured using the Physical Activity Stages of Change International Physical Activity Questionnaire (short) 3. Acceptability of activity monitors measured with questionnaire items at 1 week 4. Feasibility outcomes for activity monitors (self report at 1 week): 4.1. Number of days worn 4.2. Reported problems with wearing the monitor 4.3. Reported pain or discomfort while wearing the monitor 4.4. Reported duration and reasons for removing the monitor early (activPAL) or not wearing the monitor (FitBit)	—

Measure

Time frame

1. Framework analyses of semi-structured interviews with patients with moderate-severe chronic pain 2. Questionnaires at baseline and 1 week: 2.1. Fear of movement measured using the Tampa Scale for Kinesiphobia 2.2. Anxiety and stress measured using the Anxiety and Stress Scale 21 2.3. Pain measured using the Brief pain inventory 2.4. Pain catastrophising measured using the Pain Catastrophising Scale 2.5. Self-efficacy measured using the Pain Self-efficacy Questionnaire 2.6. Physical activity measured using the Physical Activity Stages of Change International Physical Activity Questionnaire (short) 3. Acceptability of activity monitors measured with questionnaire items at 1 week 4. Feasibility outcomes for activity monitors (self report at 1 week): 4.1. Number of days worn 4.2. Reported problems with wearing the monitor 4.3. Reported pain or discomfort while wearing the monitor 4.4. Reported duration and reasons for removing the monitor early (activPAL) or not wearing the monitor (FitBit)

—

Secondary

Measure	Time frame
1. Steps measured using ActivPal over 1 week 2. Steps measured using Fitbit (if applicable) over 1 week	—

Countries

Scotland, United Kingdom

Contacts

Public ContactIan-Ju Liang

iliang001@dundee.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026